Page last updated: 2024-08-24

telmisartan and Gastrointestinal Stromal Neoplasm

telmisartan has been researched along with Gastrointestinal Stromal Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chiyo, T; Fujihara, S; Fujimori, A; Fujita, K; Iwama, H; Kobara, H; Kobayashi, N; Masaki, T; Matsui, T; Mori, H; Morishita, A; Nishiyama, N; Nomura, T; Okano, K; Oura, K; Suzuki, Y; Tadokoro, T; Tani, J; Tingting, S; Yachida, T; Yoneyama, H1

Other Studies

1 other study(ies) available for telmisartan and Gastrointestinal Stromal Neoplasm

ArticleYear
Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro.
    Molecular medicine reports, 2020, Volume: 22, Issue:2

    Topics: AMP-Activated Protein Kinases; Angiogenesis Inducing Agents; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Telmisartan; Tissue Array Analysis

2020